30‐day mortality following palliative radiotherapy

  title={30‐day mortality following palliative radiotherapy},
  author={Mollie Kain and Hayley Bennett and Ma Yi and Bridget Robinson and Melissa L James},
  journal={Journal of Medical Imaging and Radiation Oncology},
Patients dying a short time after receiving palliative radiation are unlikely to have received benefit and may experience harm. To monitor the potential for avoidable harm, 30‐day mortality following palliative radiation has been recommended for use as a quality indicator and the Royal College of Radiologist have recommended a rate of lower than 20%. At the Canterbury Regional Cancer and Haematology Service in Christchurch, New Zealand (CRCHS), we investigated 30‐day mortality and evaluated the… 

Defining the expected 30-day mortality for patients undergoing palliative radiotherapy: a meta-analysis.

Prognostication in palliative radiotherapy—ProPaRT: Accuracy of prognostic scores

Accurate prognostication can identify candidates for low-fraction PRT during the last days of life who are more likely to complete the planned treatment without interruption and had the higher accuracy, especially when used in a multidisciplinary way.

Dual Use of the METSSS Model Predicting Survival After Palliative Radiotherapy: An Exploratory Analysis

Unexpected imbalances in the METSSS risk group size resulted in lower statistical power than anticipated and further efforts towards the application of the model beyond its original objective cannot be recommended.


Clinical suspicion of Intussusception warrants barium study regardless of plain X-ray film findings, because there was no consistent inter-reader use of signs and the various signs were found generally to be either vague or nonspecific and subject to a high degree of personal interpretation.

30-Day Mortality Following Palliative Radiotherapy

Four clinical factors related to 30-DM are found of which ECOG was the most strongly associated which may help to identify terminally ill patients with poor prognosis in order to avoid unnecessary treatments.



Thirty-day mortality rate in oncology patients treated with palliative radiotherapy.

  • T. DvorakC. MorrisA. Yeung
  • Medicine
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • 2016
A baseline palliative radiation 30-day mortality rate is established at 12.6%, with the majority of patients receiving less than or equal to 10 radiation fractions and completing most if not all of their intended fractions.

Palliative radiotherapy for advanced Cancer: Are we giving it to the right patient at the right time?

Median survival and factors affecting both survival and 30-DM in the study are comparable to others, however, a 30- DM rate of 22.7% is significantly higher compared to the literature, which needs to be better selected to avoid harm to patients with limited lifespan.

30 day mortality in adult palliative radiotherapy – A retrospective population based study of 14,972 treatment episodes

  • K. SpencerE. Morris A. Crellin
  • Medicine
    Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
  • 2015

Predicting life expectancy in patients with metastatic cancer receiving palliative radiotherapy: The TEACHH model

A LE prediction model among patients receiving palliative radiotherapy that identifies those patients with short (< 3 months) and long (> 1 year) LEs is developed.

Palliative radiotherapy during the last month of life: Predictability for referring physicians and radiation oncologists.

The majority of the palliative radiotherapy courses administered to patients with advanced cancer during their last month of life may be preventable if accurate decision models for the clinic are developed, however, due to the complexity associated with the prediction of survival times in patients receiving palliatives radiotherapy, large databases are required to allow accurate models to be established.

Toxicity following palliative radiation therapy for painful metastatic bone lesions.

This study confirms that additional steps should be taken to monitor and mitigate toxicity in this vulnerable patient group and investigates the number and type of toxicity event occurring during or after pRT for bone metastases.

The palliation of symptomatic osseous metastases final results of the study by the radiation therapy oncology group

Different dose fractionation irradiation schedules have been evaluated in a randomized Radiation Therapy Oncology Group (RTOG) study to determine their palliative effectiveness in patients with osseous metastases and the low‐dose, short‐course schedules were as effective as the high‐dose protracted programs.

Palliative radiation therapy in the last 30 days of life: A systematic review.

  • K. ParkC. Lee S. Yennurajalingam
  • Medicine
    Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
  • 2017

Development and validation of a model predicting short survival (death within 30 days) after palliative radiotherapy.

It is suggested that patients with lung or bladder cancer and the adverse features mentioned above are at high risk of dying shortly after initiation of PRT and is the first decision aid specifically addressing PRT near end of life.